Press Releases
Title
Date
12 September, 2024
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
04 September, 2024
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
27 August, 2024
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
There are no press releases that match the selected filters.
View More
Stay Updated
Your email alerts were set.
The following alerts could not be set: